openPR Logo
Press release

Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Assessment and Therapeutic Activities Reviewed in H2 2017

09-01-2017 05:57 PM CET | Health & Medicine

Press release from: Market Research Hub

Market Research Hub

Market Research Hub

According to the recently published report 'Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2017'; Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) pipeline Target constitutes close to 25 molecules. Out of which approximately 22 molecules are developed by companies and remaining by the universities/institutes.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1313649

Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Soluble guanylyl cyclase (sGC) is the known receptor for nitric oxide. Binding of nitric oxide to the heme moiety of the cyclase induces its capacity to synthesize the second messenger cGMP. Although the changes in the state of the heme moiety upon exposure of enzyme to NO and its correlation to the stimulation of sGC catalytic activity.

The report 'Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2017' outlays comprehensive information on the Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 4, 3, 12 and 1 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively. Report covers products from therapy areas Cardiovascular, Ophthalmology, Metabolic Disorders, Gastrointestinal, Immunology, Oncology, Respiratory, Central Nervous System, Dermatology, Genetic Disorders, Genito Urinary System And Sex Hormones, Hematological Disorders, Infectious Disease and Toxicology which include indications Ocular Hypertension, Glaucoma, Cystic Fibrosis, Resistant Hypertension, Alzheimer's Disease, Chemotherapy Induced Peripheral Neuropathy, Chronic Heart Failure, Chronic Kidney Disease (Chronic Renal Failure), Congestive Heart Failure (Heart Failure), Coronary Artery Disease (CAD) (Ischemic Heart Disease), Diabetic Foot Ulcers, Diabetic Nephropathy, Duchenne Muscular Dystrophy, Esophageal Achalasia, Hypertension, Inflammation, Ischemic Stroke, Liver Diseases, Open-Angle Glaucoma, Optic Neuropathy, Osteoporosis, Pancreatic Cancer, Prostate Cancer, Pulmonary Hypertension, Sickle Cell Disease, Stroke, Systemic Sclerosis (Scleroderma), Tinea pedis (Athlete Foot), Vascular Dementias and Wounds.

Scope

- The report provides a snapshot of the global therapeutic landscape for Soluble Guanylate Cyclase (sGC or EC 4.6.1.2)
- The report reviews Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics and enlists all their major and minor projects
- The report assesses Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Soluble Guanylate Cyclase (sGC or EC 4.6.1.2)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Browse Full Report With TOC: http://www.marketresearchhub.com/report/soluble-guanylate-cyclase-sgc-or-ec-4612-pipeline-review-h2-2017-report.html

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Overview
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Companies Involved in Therapeutics Development
Bayer AG
Boehringer Ingelheim GmbH
Ironwood Pharmaceuticals Inc
NicOx SA
SynZyme Technologies LLC
Topadur Pharma AG
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drug Profiles
A-8R - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BAY-1101042 - Drug Profile
Continued…………..

Enquire About this Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1313649

About Market Research Hub:

 Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)

Email: press@marketresearchhub.com

Website: http://www.marketresearchhub.com/

Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Assessment and Therapeutic Activities Reviewed in H2 2017 here

News-ID: 695671 • Views:

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, Leading Players : DEWALT, Shark,Benchmark Abrasives,Bosch,Hot Max Up to 2025
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, Stiplastics S.A.S, Argo S.A, Gramb GmbH Kunststoffverarbeitung, Origin Pharma Packaging, Eastman Chemical Company, Yuyao Liantong Plastic & Mould Co., Ltd
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstock, MingYue, Conant, Wanxin, CHEMI, Nikon
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for Soluble

Water Soluble Fertilizer Market Outlook To 2024
Water Soluble Fertilizer Market Outlook To 2024: Key Product Categories (Nitrogenous, Phosphatic, Potash, Micronutrients), Crop Type (Field Crops, Horticultural, Turf & Ornamentals), Application (Fertigation, Foliar), Regional Segmentation, Competitive Dynamics, Pricing Analysis (OPP, IPP, RAP) And Segment Forecast The global water soluble fertilizer market was valued at $12.52 billion in 2016 and is forecast to grow at a steady CAGR of 8.4% between 2017 and 2024, culminating in 2024 global revenue of
Risks Associated with Water Soluble Pods may Threaten Future Progression of the …
Water soluble pods packaging is another offering by the sustainable packaging industry, which is intended to diminish waste disposal around the world. This packaging is beneficial in a lot of ways, which make its products witness a definite market growth. However, a new research report by Future Market Insights predicts an even more positive future for the market. According to this report titled ‘Water Soluble Pods Packaging Market: Global Industry
Soluble Fibers Market
https://www.qandqmarketresearch.com/reports/7321287/soluble-fibers-market-44 Soluble Fiber is a type of fiber dissolves in water to form a gellike material. It can help lower blood cholesterol and glucose levels. Soluble Fiber attracts water and turns to gel during digestion. This slows digestion. Soluble fiber is found in oat bran, barley, nuts, seeds, beans, lentils, peas, and some fruits and vegetables. It is also found in psyllium, a common fiber supplement. Some types of soluble fiber
Soluble Fertilizer Market Report 2018: Segmentation by Product (NPK Water-solubl …
Global Soluble Fertilizer market research report provides company profile for Everris, Bunge, SQM, UralChem, ICL Fertilizers, Sinclair, Haifa Chemicals, Yara, Arab Potash Company, Omex and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The
Soluble Fiber Market empirical assessment 2024
Global Soluble Fiber Market: Overview This report on the global soluble fiber market is a comprehensive market intelligence study that brings forth the lucrativeness of the said market. Beginning with an executive summary that comprise a snapshot of how the demand for soluble fiber has evolved over the recent past and where is it headed to in the future, the report delves into the analysis of various market dynamics, such as
Soluble Fibers Market 2024: Comprehensive Research Report
Soluble Fibers Market will surpass USD 5.5 Billion by 2024; according to a new research report by Global Market Insights, Inc. Soluble fibers market demand will be mainly driven by the increasing awareness regarding the health benefits offered by the product among the U.S and European population, coupled with a significant growth in the functional food & beverages sector. The product is widely used in the edible and conventional food items